Key result
Polypharmacy (concurrent use of ≥ 5 medications) was present in 76.3% of elderly patients discharged from medical wards, and was associated with comorbidities and cardiovascular disease.
Cross-Sectional
No
Polypharmacy is highly prevalent (76.3%) among elderly medical patients discharged from a tertiary hospital in Oman, particularly those with cardiovascular disease.
Polypharmacy patterns in Omani elderly may prompt local audits; leaves open whether interventions reduce adverse outcomes.
OBJECTIVES: To evaluate the prevalence of polypharmacy in relation to gender, comorbidity, and age among elderly patients upon discharge from an academic tertiary care hospital in Muscat, Oman. METHODS: This cross-sectional study was conducted at Sultan Qaboos University Hospital between February and July 2014. We reviewed the electronic medical records of elderly patients aged ≥ 60 years who were admitted to any of the hospital's medical wards during the study period and collected data on age, gender, and diagnoses. We also collected information on the medications prescribed on discharge. Polypharmacy was defined as the concurrent use of ≥ 5 medications. RESULTS: 0.001). More patients had cardiovascular diseases on admission (31.0%), followed by infections (23.0%), and gastrointestinal diseases (13.0%). The most commonly prescribed drugs on discharge were cardiovascular drugs (48.0%), followed by drugs acting on the gastrointestinal system (11.0%), endocrine system (9.2%), and nutrition and blood (7.5%). CONCLUSIONS: The prevalence of polypharmacy among elderly medical patients discharged from our hospital was high (76.3%) and was associated with a number of comorbidities and cardiovascular disease as a cause of admission, but not with age or gender. The prevalence of polypharmacy in our institution raises significant concerns over its potential impact on patients' health outcomes and requires further investigation. Raising physicians' awareness of health implications of polypharmacy may help reduce the incidence of medication-related adverse events and improve treatment outcomes.
No takes yet. Share an insight, caveat, or question.
Al‐Hashar et al. (2016) conducted a cross-sectional in Polypharmacy. Polypharmacy was evaluated on Prevalence of polypharmacy. Polypharmacy (concurrent use of ≥ 5 medications) was present in 76.3% of elderly patients discharged from medical wards, and was associated with comorbidities and cardiovascular disease.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: